Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Tuesday, September 29

2:45 PM - 2:55 PM ET

338 - Development and Validation of a Vendor-Neutral Backup and Recovery Software for Cyberattack Resiliency
Speaker: Liang, Danfu, PhD - Thomas Jefferson University, Philadelphia, PA
2:45 PM - 2:55 PM ET

LBA 07 - A Phase II Trial of Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma
Speaker: Raju-Salicki, Silpa, MD - Washington University in St. Louis, St. Louis, MO
2:55 PM - 3:00 PM ET

131 - Subsequent Tumors Following Pencil Beam Scanning Proton Radiotherapy
Speaker: Lucas, John, MD, MS - St. Jude Children's Research Hospital, Memphis, TN
2:55 PM - 3:05 PM ET

284 - Clinicogenomic Risk Stratification Identifies Metastatic Breast Cancer Patients at High Risk for Symptomatic Brain Metastases
Speaker: Pike, Luke, MD, DPhil - Memorial Sloan Kettering Cancer Center, New York, New York
2:55 PM - 3:05 PM ET

290 - Intratumoral-Peritumoral CT Radiomics with Machine Learning for Predicting Local Tumor Response after Radiotherapy in Non-Small Cell Lung Cancer
Speaker: Chen, Zhi, MD - West China Longquan Hospital, Sichuan University/The First People's Hospital of Longquanyi District, Chengdu, Sichuan
2:55 PM - 3:05 PM ET

297 - Planning, Delivery and Safety of Dose-Escalated Radiation in GRECO2: Secondary Analysis of a Large International Randomized Trial for Localized Pancreatic Cancer
Speaker: Kuehnle, Ryan, MD - UT Southwestern Medical Center, Dallas, TX
2:55 PM - 3:05 PM ET

302 - Fluorescence Tracking of Tumor-Draining Lymph Node-Derived CD8 T Cell Responses Following Tumor Radiation
Speaker: Friedman, David, PhD - Earle A. Chiles Research Institute, Portland, OR
2:55 PM - 3:05 PM ET

308 - Patterns of Nodal Failure after Cervical Cancer Chemoradiotherapy: The Role of Geometric Miss and Baseline Nodal Signal
Speaker: Su, Shiqin, PhD - University of Texas MD Anderson Cancer Center, Houston, TX
2:55 PM - 3:05 PM ET

339 - From Clinical Trials to Clinical Practice: An Analysis of Reproducibility and Transparency in High-Impact Radiation Oncology Trials
Speaker: Quirk, Sarah, PhD - Mass General Brigham and Harvard Medical School, Boston, MA
2:55 PM - 3:05 PM ET

LBA 08 - A Randomized, Phase II Clinical Trial of Stereotactic Body Radiation Therapy Or Conventionally Fractionated Concurrent Chemotherapy and Radiation Therapy Preoperatively for Pancreatic Adenocarcinoma, the SOFT Preop Study
Speaker: Hall, William, MD - Medical College of Wisconsin, Milwaukee, WI
3:00 PM - 3:10 PM ET

Discussant
Speaker: Milgrom, Sarah, MD - University of Colorado School of Medicine, Aurora, CO
3:05 PM - 3:15 PM ET

1214 - Proton vs. Photon EBRT for Hepatocellular Carcinoma: A Multi-Institutional Individual Patient Data Analysis Using Propensity Score Weighting
Speaker: Yanagihara, Ted, MD, PhD - University of North Carolina, Chapel Hill, NC